New drug. With 15-PGDH in the BBB as the focus, the team used a drug (SW033291) they developed at Case Western Reserve School of Medicine and University Hospitals to block the enzyme.

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...

Based on their results, the scientists are hopeful the drug could help treat AD, brain injuries and possibly other brain diseases. Reference: Koh Y, Vázquez-Rosa E, Gao F, et al. Inhibiting 15-PGDH ...

Cholesterol-lowering medicines are some of the most commonly prescribed, effective drugs. But to influencers on TikTok, ...

Discover 5 dangerous drug-resistant fungi posing epidemic threats. Learn how these deadly superbugs are spreading and what ...

A multi-strain probiotic blend shows promise for protecting brain function by reducing gut-triggered inflammation linked to ...

DelveInsight's Traumatic Brain Injury pipeline report depicts a robust space with 20+ active players working to develop 22+ ...

Brain swelling, or cerebral edema, is a medical emergency. Learn about the evidence-based treatments doctors use to reduce ...

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as "chemo brain." These effects resemble ...

HONG KONG SAR - Media OutReach Newswire - 6 December 2023 - A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer's disease (AD). The ...

Administration of acetaminophen within 48h of intensive care unit admission was associated with reduced short- and long-term ...